首页 > 最新文献

Journal of intensive medicine最新文献

英文 中文
Anemia as a potent marker of in-hospital mortality in patients admitted to the cardiac intensive care unit: Data from the Critical Care Cardiology Trials Network (CCCTN) Registry 贫血是心脏重症监护病房入院患者住院死亡率的一个有效标志:来自重症监护心脏病学试验网络(CCCTN)注册的数据
Pub Date : 2025-07-01 DOI: 10.1016/j.jointm.2024.12.006
Christine Chow , Rasheed Durowoju , Carlos Alviar , Gregory W Barsness , Howard A Cooper , Lori B Daniels , Xuan Ding , Shahab Ghafghazi , Umesh Gidwani , Michael Goldfarb , Dustin Hillerson , Jason N Katz , Paul Marano , Jeong-Gun Park , Matthew Pierce , Scott W Rose , Robert O Roswell , Sean van Diepen , Anjali Wagle , Erin A Bohula , Younghoon Kwon

Background

Anemia is common in critically ill patients and is associated with poor outcomes. We investigated the prevalence of anemia and its association with in-hospital outcomes among patients admitted to cardiac intensive care units (CICUs) and subgroups within this population.

Methods

The Critical Care Cardiology Trials Network (CCCTN) is a multicenter network of tertiary CICUs in North America. CICU admissions with available baseline hemoglobin (Hgb) between 2017 and 2023 were included in this analysis. Patients were stratified by Hgb levels (Hgb <8 g/dL, 8 g/dL ≤ Hgb <10 g/dL, 10 g/dL ≤ Hgb <12 g/dL, 12 g/dL ≤ Hgb <14 g/dL, and ≥14 g/dL). The ≥14 g/dL group was used for reference. The association of Hgb level and in-hospital mortality was examined by multivariable logistic regression.

Results

Among 28,585 patient admissions (median age 67 years, 36.7 % female), the median Hgb was 12.1 g/dL (interquartile range: 10.1–13.9), with 48.3 % of patients who meet criteria for anemia (Hgb <12 g/dL). The adjusted relative odds of in-hospital mortality was highest for patients with Hgb <8 g/dL (1.60, 95 % confidence interval [CI]: 1.35 to 1.89, P < 0.0001), followed by patients with 8 g/dL≤ Hgb <10 g/dL (adjusted relative odds =1.51, 95 % CI: 1.32 to 1.73, P < 0.0001), and patients with Hgb 10 g/dL≤ Hgb<12 g/dL (adjusted relative odds=1.24, 95 % CI: 1.09 to 1.41, P=0.0012). This association was present among those with non-acute coronary syndrome (ACS) cardiogenic shock (n=4255) and those with non-cardiogenic shock ACS (n=7194).

Conclusions

Anemia was present in nearly half of patients admitted to CICUs. Lower admission Hgb is independently associated with higher in-hospital mortality in a graded relationship among patients with cardiac critical illness.
背景:贫血在危重患者中很常见,并与不良预后相关。我们调查了心脏重症监护病房(CICUs)住院患者及其亚组中贫血的患病率及其与住院预后的关系。方法重症监护心脏病学试验网络(CCCTN)是北美三级重症监护中心的多中心网络。该分析纳入了2017年至2023年期间可用基线血红蛋白(Hgb)的CICU入院患者。患者按Hgb水平分层(Hgb <、8g /dL、8g /dL≤Hgb <、10g /dL、10g /dL≤Hgb <、12g /dL、12g /dL≤Hgb <、14g /dL、≥14g /dL)。≥14 g/dL组为参考。采用多变量logistic回归检验Hgb水平与住院死亡率的关系。结果28,585例入院患者(中位年龄67岁,36.7% %女性)中位Hgb为12.1 g/dL(四分位数范围:10.1-13.9),48.3% %的患者符合贫血标准(Hgb <12 g/dL)。Hgb <;8 g/dL患者的调整后住院死亡率相对赔率最高(1.60,95 %置信区间[CI]: 1.35 ~ 1.89, P <;0.0001),其次是8 g/dL≤Hgb <;10 g/dL(校正相对优势=1.51,95 % CI: 1.32 ~ 1.73, P <;0.0001), hgb10g /dL≤hgb12g /dL患者(校正相对优势=1.24,95 % CI: 1.09 ~ 1.41, P=0.0012)。在非急性冠脉综合征(ACS)心源性休克(n=4255)和非心源性休克ACS (n=7194)患者中存在这种关联。结论近半数住院患者存在贫血。在心脏危重症患者中,较低的入院Hgb与较高的住院死亡率呈分级关系独立相关。
{"title":"Anemia as a potent marker of in-hospital mortality in patients admitted to the cardiac intensive care unit: Data from the Critical Care Cardiology Trials Network (CCCTN) Registry","authors":"Christine Chow ,&nbsp;Rasheed Durowoju ,&nbsp;Carlos Alviar ,&nbsp;Gregory W Barsness ,&nbsp;Howard A Cooper ,&nbsp;Lori B Daniels ,&nbsp;Xuan Ding ,&nbsp;Shahab Ghafghazi ,&nbsp;Umesh Gidwani ,&nbsp;Michael Goldfarb ,&nbsp;Dustin Hillerson ,&nbsp;Jason N Katz ,&nbsp;Paul Marano ,&nbsp;Jeong-Gun Park ,&nbsp;Matthew Pierce ,&nbsp;Scott W Rose ,&nbsp;Robert O Roswell ,&nbsp;Sean van Diepen ,&nbsp;Anjali Wagle ,&nbsp;Erin A Bohula ,&nbsp;Younghoon Kwon","doi":"10.1016/j.jointm.2024.12.006","DOIUrl":"10.1016/j.jointm.2024.12.006","url":null,"abstract":"<div><h3>Background</h3><div>Anemia is common in critically ill patients and is associated with poor outcomes. We investigated the prevalence of anemia and its association with in-hospital outcomes among patients admitted to cardiac intensive care units (CICUs) and subgroups within this population.</div></div><div><h3>Methods</h3><div>The Critical Care Cardiology Trials Network (CCCTN) is a multicenter network of tertiary CICUs in North America. CICU admissions with available baseline hemoglobin (Hgb) between 2017 and 2023 were included in this analysis. Patients were stratified by Hgb levels (Hgb &lt;8 g/dL, 8 g/dL ≤ Hgb &lt;10 g/dL, 10 g/dL ≤ Hgb &lt;12 g/dL, 12 g/dL ≤ Hgb &lt;14 g/dL, and ≥14 g/dL). The ≥14 g/dL group was used for reference. The association of Hgb level and in-hospital mortality was examined by multivariable logistic regression.</div></div><div><h3>Results</h3><div>Among 28,585 patient admissions (median age 67 years, 36.7 % female), the median Hgb was 12.1 g/dL (interquartile range: 10.1–13.9), with 48.3 % of patients who meet criteria for anemia (Hgb &lt;12 g/dL). The adjusted relative odds of in-hospital mortality was highest for patients with Hgb &lt;8 g/dL (1.60, 95 % confidence interval [CI]: 1.35 to 1.89, <em>P</em> &lt; 0.0001), followed by patients with 8 g/dL≤ Hgb &lt;10 g/dL (adjusted relative odds =1.51, 95 % CI: 1.32 to 1.73, <em>P</em> &lt; 0.0001), and patients with Hgb 10 g/dL≤ Hgb&lt;12 g/dL (adjusted relative odds=1.24, 95 % CI: 1.09 to 1.41, <em>P</em>=0.0012). This association was present among those with non-acute coronary syndrome (ACS) cardiogenic shock (<em>n</em>=4255) and those with non-cardiogenic shock ACS (<em>n</em>=7194).</div></div><div><h3>Conclusions</h3><div>Anemia was present in nearly half of patients admitted to CICUs. Lower admission Hgb is independently associated with higher in-hospital mortality in a graded relationship among patients with cardiac critical illness.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 3","pages":"Pages 262-268"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The glyoxalase system: A new target for inflammatory diseases 乙二醛酶系统:炎症性疾病的新靶点
Pub Date : 2025-07-01 DOI: 10.1016/j.jointm.2025.03.002
Yingyi Yang , Rui Kang , Huiting Zhou , Daolin Tang
{"title":"The glyoxalase system: A new target for inflammatory diseases","authors":"Yingyi Yang ,&nbsp;Rui Kang ,&nbsp;Huiting Zhou ,&nbsp;Daolin Tang","doi":"10.1016/j.jointm.2025.03.002","DOIUrl":"10.1016/j.jointm.2025.03.002","url":null,"abstract":"","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 3","pages":"Pages 216-218"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CHA2DS2-VASc scores to predict left atrial/left atrial appendage abnormalities in patients with sepsis-induced atrial fibrillation: A preliminary investigation CHA2DS2-VASc评分预测脓毒症心房颤动患者左房/左房附件异常的初步研究
Pub Date : 2025-07-01 DOI: 10.1016/j.jointm.2024.12.007
Vincent Labbé , Stephane Ederhy , David Legouis , Jérémie Joffre , Keyvan Razazi , Oumar Sy , Frank Chemouni , Armand Mekontso Dessap , Muriel Fartoukh , Ariel Cohen , FAST Study Group
{"title":"CHA2DS2-VASc scores to predict left atrial/left atrial appendage abnormalities in patients with sepsis-induced atrial fibrillation: A preliminary investigation","authors":"Vincent Labbé ,&nbsp;Stephane Ederhy ,&nbsp;David Legouis ,&nbsp;Jérémie Joffre ,&nbsp;Keyvan Razazi ,&nbsp;Oumar Sy ,&nbsp;Frank Chemouni ,&nbsp;Armand Mekontso Dessap ,&nbsp;Muriel Fartoukh ,&nbsp;Ariel Cohen ,&nbsp;FAST Study Group","doi":"10.1016/j.jointm.2024.12.007","DOIUrl":"10.1016/j.jointm.2024.12.007","url":null,"abstract":"","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 3","pages":"Pages 288-291"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Title Page 标题页
Pub Date : 2025-03-29 DOI: 10.1016/S2667-100X(25)00007-6
{"title":"Title Page","authors":"","doi":"10.1016/S2667-100X(25)00007-6","DOIUrl":"10.1016/S2667-100X(25)00007-6","url":null,"abstract":"","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 2","pages":"Pages i-ii"},"PeriodicalIF":0.0,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143724783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting multiple organ dysfunction syndrome in trauma-induced sepsis: Nomogram and machine learning approaches 预测创伤性败血症中的多器官功能障碍综合征:Nomogram和machine learning方法
Pub Date : 2025-02-08 DOI: 10.1016/j.jointm.2024.12.008
Jinyu Peng , Yun Li , Chao Liu , Zhi Mao , Hongjun Kang , Feihu Zhou

Background

Multiple organ dysfunction syndrome (MODS) is a critical complication in trauma-induced sepsis patients and is associated with a high mortality rate. This study aimed to develop and validate predictive models for MODS in this patient population using a nomogram and machine learning approaches.

Methods

This retrospective cohort study utilized data from the Medical Information Mart for Intensive Care-IV 2.2 database, focusing on trauma patients diagnosed with sepsis within the first day of intensive care unit (ICU) admission. Predictive variables were extracted from the initial 24 h of ICU data. The dataset (2008–2019) was divided into a training set (2008–2016) and a temporal validation set (2017–2019). Feature selection was conducted using the Boruta algorithm. Predictive models were developed and validated using a nomogram and various machine learning techniques. Model performance was evaluated based on discrimination, calibration, and decision curve analysis.

Results

Among 1295 trauma patients with sepsis, 349 (26.95%) developed MODS. The 28-day mortality rates were 11.21% for non-MODS patients and 23.82% for MODS patients. Key predictors of MODS included the simplified acute physiology score II score, use of mechanical ventilation, and vasopressor administration. In temporal validation, all models significantly outperformed traditional scoring systems (all P <0.05). The nomogram achieved an area under the curve (AUC) of 0.757 (95% confidence interval [CI]: 0.700 to 0.814), while the random forest model demonstrated the highest performance with an AUC of 0.769 (95% CI: 0.712 to 0.826). Calibration plots showed excellent agreement between predicted and observed probabilities, and decision curve analysis indicated a consistently higher net benefit for the newly developed models.

Conclusion

The nomogram and machine learning models provide enhanced predictive accuracy for MODS in trauma-induced sepsis patients compared to traditional scoring systems. These tools, accessible via web-based applications, have the potential to improve early risk stratification and guide clinical decision-making, ultimately enhancing outcomes for trauma patients. Further external validation is recommended to confirm their generalizability.
背景:多器官功能障碍综合征(MODS)是创伤性脓毒症患者的重要并发症,死亡率高。本研究旨在利用nomogram和机器学习方法开发并验证该患者群体MODS的预测模型。方法本回顾性队列研究利用重症监护医学信息市场- iv - 2.2数据库的数据,重点研究重症监护病房(ICU)入院第一天诊断为败血症的创伤患者。从ICU的最初24小时数据中提取预测变量。数据集(2008-2019)分为训练集(2008-2016)和时间验证集(2017-2019)。采用Boruta算法进行特征选择。使用nomogram和各种机器学习技术开发并验证了预测模型。基于判别、校准和决策曲线分析对模型性能进行评估。结果1295例创伤脓毒症患者中,349例(26.95%)发生MODS。非MODS患者28天死亡率为11.21%,MODS患者为23.82%。MODS的主要预测因素包括简化急性生理评分、机械通气的使用和血管加压药的使用。在时间验证中,所有模型都显著优于传统评分系统(均P <;0.05)。模态图的曲线下面积(AUC)为0.757(95%可信区间[CI]: 0.700至0.814),而随机森林模型的AUC为0.769 (95% CI: 0.712至0.826),表现出最高的性能。校正图显示预测概率和观测概率非常吻合,决策曲线分析表明新开发模型的净效益始终较高。结论与传统评分系统相比,nomogram和machine learning模型可提高创伤性败血症患者MODS的预测准确性。这些工具可通过基于网络的应用程序访问,具有改善早期风险分层和指导临床决策的潜力,最终提高创伤患者的预后。建议进一步进行外部验证以确认其通用性。
{"title":"Predicting multiple organ dysfunction syndrome in trauma-induced sepsis: Nomogram and machine learning approaches","authors":"Jinyu Peng ,&nbsp;Yun Li ,&nbsp;Chao Liu ,&nbsp;Zhi Mao ,&nbsp;Hongjun Kang ,&nbsp;Feihu Zhou","doi":"10.1016/j.jointm.2024.12.008","DOIUrl":"10.1016/j.jointm.2024.12.008","url":null,"abstract":"<div><h3>Background</h3><div>Multiple organ dysfunction syndrome (MODS) is a critical complication in trauma-induced sepsis patients and is associated with a high mortality rate. This study aimed to develop and validate predictive models for MODS in this patient population using a nomogram and machine learning approaches.</div></div><div><h3>Methods</h3><div>This retrospective cohort study utilized data from the Medical Information Mart for Intensive Care-IV 2.2 database, focusing on trauma patients diagnosed with sepsis within the first day of intensive care unit (ICU) admission. Predictive variables were extracted from the initial 24 h of ICU data. The dataset (2008–2019) was divided into a training set (2008–2016) and a temporal validation set (2017–2019). Feature selection was conducted using the Boruta algorithm. Predictive models were developed and validated using a nomogram and various machine learning techniques. Model performance was evaluated based on discrimination, calibration, and decision curve analysis.</div></div><div><h3>Results</h3><div>Among 1295 trauma patients with sepsis, 349 (26.95%) developed MODS. The 28-day mortality rates were 11.21% for non-MODS patients and 23.82% for MODS patients. Key predictors of MODS included the simplified acute physiology score II score, use of mechanical ventilation, and vasopressor administration. In temporal validation, all models significantly outperformed traditional scoring systems (all <em>P</em> &lt;0.05). The nomogram achieved an area under the curve (AUC) of 0.757 (95% confidence interval [CI]: 0.700 to 0.814), while the random forest model demonstrated the highest performance with an AUC of 0.769 (95% CI: 0.712 to 0.826). Calibration plots showed excellent agreement between predicted and observed probabilities, and decision curve analysis indicated a consistently higher net benefit for the newly developed models.</div></div><div><h3>Conclusion</h3><div>The nomogram and machine learning models provide enhanced predictive accuracy for MODS in trauma-induced sepsis patients compared to traditional scoring systems. These tools, accessible via web-based applications, have the potential to improve early risk stratification and guide clinical decision-making, ultimately enhancing outcomes for trauma patients. Further external validation is recommended to confirm their generalizability.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 2","pages":"Pages 193-201"},"PeriodicalIF":0.0,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143724780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Causes of fulminant tropical probable myocarditis: A retrospective cohort study in the French West Indies 暴发性热带可能心肌炎的病因:法属西印度群岛的一项回顾性队列研究。
Pub Date : 2025-01-01 DOI: 10.1016/j.jointm.2024.07.001
Laurent Camous , Nicolas Paulo , Frederic Martino , Sylvaine Bastian , Marc Valette , Jean-David Pommier
{"title":"Causes of fulminant tropical probable myocarditis: A retrospective cohort study in the French West Indies","authors":"Laurent Camous ,&nbsp;Nicolas Paulo ,&nbsp;Frederic Martino ,&nbsp;Sylvaine Bastian ,&nbsp;Marc Valette ,&nbsp;Jean-David Pommier","doi":"10.1016/j.jointm.2024.07.001","DOIUrl":"10.1016/j.jointm.2024.07.001","url":null,"abstract":"","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 1","pages":"Pages 111-112"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11763240/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143054388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes and risk factors of transported patients with extracorporeal membrane oxygenation: An ECMO center experience 体外膜氧合转运患者的疗效和风险因素:ECMO 中心的经验
Pub Date : 2025-01-01 DOI: 10.1016/j.jointm.2024.04.003
Lingjuan Liu , Dingji Hu , Tong Hao , Shanshan Chen , Lei Chen , Yike Zhu , Chenhui Jin , Jing Wu , Haoya Fu , Haibo Qiu , Yi Yang , Songqiao Liu

Background

Extracorporeal membrane oxygenation (ECMO) has been proven to be a support method and technology for patients with cardiopulmonary failure. However, the transport of patients under ECMO support is challenging given the high-risk technical maneuvers and patient-care concerns involved. Herein, we examined the safety of ECMO during the transport of critically ill patients and its impact on mortality rates, to provide more secure and effective transport strategies in clinical practice.

Method

To assess the safety of ECMO patient transport, this study conducted a retrospective analysis on critically ill adults who required ECMO support and transport at the intensive care unit (ICU) center between 2017 and 2023. The study utilized standard ECMO transport protocols and conducted a comprehensive statistical analysis of the collected clinical data and transport processes. The 28-day survival rate for ECMO patients was determined using Kaplan–Meier analysis, while logistic regression identified prognostic factors.

Result

Out of 303 patients supported with ECMO, 111 (36.6%) were transported. 69.4% of the transport group were male, mean age was (42.0±17.0) years, mean body mass index was (24.4±4.6) kg/m2, and veno-arterial-ECMO accounted for 52.5%. The median transportation distance was 190 (interquartile range [IQR]: 70–260) km, and the longest distance was 8100 km. The median transit time was 180 (IQR: 100–260) min, and the maximum duration was 1720 min. No severe adverse events including death or mechanical failure occurred during transportation. The 28-day survival rate was 64.7% (n=196) and ICU survival rate was 56.1% (n=170) for the entire cohort; whereas, the 28-day survival rate was 72.1% (n=80) and ICU survival rate was 66.7% (n=74) in the transport group. A non-significant difference in 28-day survival was observed between the two groups after propensity score matching (P=0.56). Additionally, we found that acute physiology and chronic health evaluation II score (odds ratio [OR]=1.06, P <0.01), lactate levels (>5 mmol/L, OR=2.80, P=0.01), and renal replacement therapy initiation (OR=3.03, P <0.01) were associated with increased mortality risk.

Conclusion

Transporting patients on ECMO between medical facilities is a safe procedure that does not increase patient mortality rates, provided it is orchestrated and executed by proficient transport teams. The prognostic outcome for these patients is predominantly influenced by their pre-existing medical conditions or by complications that may develop during the course of ECMO therapy. These results form the basis for the creation of specialized ECMO network hubs within healthcare regions.
体外膜氧合(ECMO)已被证明是一种支持心肺衰竭患者的方法和技术。然而,考虑到高风险的技术操作和涉及的患者护理问题,在ECMO支持下运送患者是具有挑战性的。在此,我们研究了重症患者转运过程中ECMO的安全性及其对死亡率的影响,以期在临床实践中提供更安全有效的转运策略。方法为了评估ECMO患者运输的安全性,本研究对2017年至2023年在重症监护病房(ICU)中心需要ECMO支持和运输的危重成人患者进行回顾性分析。本研究采用标准ECMO转运方案,并对收集到的临床数据和转运过程进行了全面的统计分析。采用Kaplan-Meier分析确定ECMO患者的28天生存率,同时采用logistic回归确定预后因素。结果303例ECMO患者中,111例(36.6%)被转移。转运组69.4%为男性,平均年龄(42.0±17.0)岁,平均体重指数(24.4±4.6)kg/m2,静脉-动脉- ecmo占52.5%。运输距离中位数为190 km(四分位间距[IQR]: 70-260),最长运输距离为8100 km。中位运输时间为180 (IQR: 100-260) min,最长时间为1720 min。运输过程中未发生包括死亡或机械故障在内的严重不良事件。整个队列28天生存率为64.7% (n=196), ICU生存率为56.1% (n=170);转运组28天生存率为72.1% (n=80), ICU生存率为66.7% (n=74)。倾向评分匹配后,两组28天生存率无显著差异(P=0.56)。此外,我们发现急性生理和慢性健康评估II评分(优势比[OR]=1.06, P <0.01)、乳酸水平(>5 mmol/L, OR=2.80, P=0.01)和肾脏替代治疗开始(OR=3.03, P <0.01)与死亡风险增加相关。结论:在不同医疗机构之间进行ECMO患者的转运是一种安全的操作,如果由熟练的转运团队精心安排和执行,不会增加患者的死亡率。这些患者的预后主要受其先前存在的医疗状况或在ECMO治疗过程中可能出现的并发症的影响。这些结果构成了在医疗保健区域内创建专门ECMO网络中心的基础。
{"title":"Outcomes and risk factors of transported patients with extracorporeal membrane oxygenation: An ECMO center experience","authors":"Lingjuan Liu ,&nbsp;Dingji Hu ,&nbsp;Tong Hao ,&nbsp;Shanshan Chen ,&nbsp;Lei Chen ,&nbsp;Yike Zhu ,&nbsp;Chenhui Jin ,&nbsp;Jing Wu ,&nbsp;Haoya Fu ,&nbsp;Haibo Qiu ,&nbsp;Yi Yang ,&nbsp;Songqiao Liu","doi":"10.1016/j.jointm.2024.04.003","DOIUrl":"10.1016/j.jointm.2024.04.003","url":null,"abstract":"<div><h3>Background</h3><div>Extracorporeal membrane oxygenation (ECMO) has been proven to be a support method and technology for patients with cardiopulmonary failure. However, the transport of patients under ECMO support is challenging given the high-risk technical maneuvers and patient-care concerns involved. Herein, we examined the safety of ECMO during the transport of critically ill patients and its impact on mortality rates, to provide more secure and effective transport strategies in clinical practice.</div></div><div><h3>Method</h3><div>To assess the safety of ECMO patient transport, this study conducted a retrospective analysis on critically ill adults who required ECMO support and transport at the intensive care unit (ICU) center between 2017 and 2023. The study utilized standard ECMO transport protocols and conducted a comprehensive statistical analysis of the collected clinical data and transport processes. The 28-day survival rate for ECMO patients was determined using Kaplan–Meier analysis, while logistic regression identified prognostic factors.</div></div><div><h3>Result</h3><div>Out of 303 patients supported with ECMO, 111 (36.6%) were transported. 69.4% of the transport group were male, mean age was (42.0±17.0) years, mean body mass index was (24.4±4.6) kg/m<sup>2</sup>, and veno-arterial-ECMO accounted for 52.5%. The median transportation distance was 190 (interquartile range [IQR]: 70–260) km, and the longest distance was 8100 km. The median transit time was 180 (IQR: 100–260) min, and the maximum duration was 1720 min. No severe adverse events including death or mechanical failure occurred during transportation. The 28-day survival rate was 64.7% (<em>n</em>=196) and ICU survival rate was 56.1% (<em>n</em>=170) for the entire cohort; whereas, the 28-day survival rate was 72.1% (<em>n</em>=80) and ICU survival rate was 66.7% (<em>n</em>=74) in the transport group. A non-significant difference in 28-day survival was observed between the two groups after propensity score matching (<em>P</em>=0.56). Additionally, we found that acute physiology and chronic health evaluation II score (odds ratio [OR]=1.06, <em>P</em> &lt;0.01), lactate levels (&gt;5 mmol/L, OR=2.80, <em>P</em>=0.01), and renal replacement therapy initiation (OR=3.03, <em>P</em> &lt;0.01) were associated with increased mortality risk.</div></div><div><h3>Conclusion</h3><div>Transporting patients on ECMO between medical facilities is a safe procedure that does not increase patient mortality rates, provided it is orchestrated and executed by proficient transport teams. The prognostic outcome for these patients is predominantly influenced by their pre-existing medical conditions or by complications that may develop during the course of ECMO therapy. These results form the basis for the creation of specialized ECMO network hubs within healthcare regions.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 1","pages":"Pages 35-42"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141396556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A modified screening protocol for ARDS in patients with respiratory support based on SpO2 and FiO2: A single-center prospective, observational study 基于SpO2和FiO2的呼吸支持患者ARDS改进筛查方案:一项单中心前瞻性观察性研究。
Pub Date : 2025-01-01 DOI: 10.1016/j.jointm.2024.06.002
Yan Xia , Qiancheng Xu , Zhiyuan Guo , Huijuan Zhang , Yingya Cao , Yupeng Qi , Qun Chen , Weihua Lu

Background

The purpose is to formulate a modified screening protocol for acute respiratory distress syndrome (ARDS) in patients with respiratory support based on saturation of pulse oximetry (SpO2) and inspired oxygen concentration (FiO2).

Methods

This prospective observational study was conducted from August to October 2020 at the Department of Critical Care Medicine of Yijishan Hospital Affiliated with Wannan Medical College. All patients admitted during the study period and required arterial blood gas analysis and electrocardiogram monitoring were included in this study. Patients with contraindications to arterial puncture, methemoglobinemia, carbon monoxide poisoning, and other factors that could affect data collection were excluded. The demographic and clinical data, immediate percutaneous SpO2, FiO2, arterial oxygen partial pressure (PaO2), and respiratory rate were recorded; and the SpO2/FiO2 ratio (SFR) and PaO2/FiO2 ratio (PFR) values were calculated according to the above information. The patients were divided into two cohorts by random number table: the establishment cohort and the verification cohort. In the established part, data were divided into group H and group N according to whether SpO2 >97 %. For group H (SpO2 ≤97 %), the regression equation was established between SFR and PFR. For group N (SpO2 >97 %), the correlation between each observation data and PFR was analyzed. Then, a new diagnostic process was established, and the reliability was verified with the Berlin definition set as the gold standard for diagnosis and classification.

Results

There were 341 patients were included. Among them, 161 patients were used to establish the model, and 180 patients were used to verify the validity of the model. In this new diagnosis progress, when SpO2 ≤97 %, if SFR ≤352, ARDS may exist; when SpO2 >97 %, if FiO2min >39 %, there may be ARDS. The sensitivity, specificity, negative predictive value, positive predictive value, and accuracy of the new diagnosis progress for ARDS were 91.1 %, 76.7 %, 89.6 %, 79.6 %, and 83.9 %, respectively.

Conclusion

The SpO2/FiO2 ratio demonstrates notable sensitivity and specificity in diagnosing ARDS, presenting as a credible alternative to PFR.
Trail Registration Chinese Clinical Trial Registry Identifier: ChiCTR2000029217
背景:目的:基于脉搏血氧饱和度(SpO2)和吸入氧浓度(FiO2)制定呼吸支持患者急性呼吸窘迫综合征(ARDS)的改进筛查方案。方法:本前瞻性观察研究于2020年8月至10月在皖南医学院附属一积山医院重症医学科进行。所有在研究期间入院并需要进行动脉血气分析和心电图监测的患者均纳入本研究。排除动脉穿刺禁忌症、高铁血红蛋白血症、一氧化碳中毒等可能影响数据收集的因素。记录患者的人口统计学和临床资料,即时经皮SpO2、FiO2、动脉氧分压(PaO2)和呼吸频率;并根据上述信息计算SpO2/FiO2比值(SFR)和PaO2/FiO2比值(PFR)值。采用随机数字表法将患者分为两组:建立组和验证组。在所建立的部分中,根据SpO2是否达到97%将数据分为H组和N组。H组(SpO2≤97%),SFR与PFR之间建立回归方程。对于N组(SpO2 bb0 97%),分析各观测数据与PFR的相关性。然后,建立了一种新的诊断流程,并以柏林定义集作为诊断和分类的金标准,验证了可靠性。结果:共纳入341例患者。其中,用161例患者建立模型,用180例患者验证模型的有效性。在这一新诊断进展中,当SpO2≤97%,SFR≤352时,可能存在ARDS;当SpO2 >为97%,FiO2min >为39%时,可能发生ARDS。ARDS新诊断进展的敏感性、特异性、阴性预测值、阳性预测值和准确率分别为91.1%、76.7%、89.6%、79.6%和83.9%。结论:SpO2/FiO2比值诊断ARDS具有明显的敏感性和特异性,可作为PFR的可靠替代指标。中国临床试验注册号:ChiCTR2000029217。
{"title":"A modified screening protocol for ARDS in patients with respiratory support based on SpO2 and FiO2: A single-center prospective, observational study","authors":"Yan Xia ,&nbsp;Qiancheng Xu ,&nbsp;Zhiyuan Guo ,&nbsp;Huijuan Zhang ,&nbsp;Yingya Cao ,&nbsp;Yupeng Qi ,&nbsp;Qun Chen ,&nbsp;Weihua Lu","doi":"10.1016/j.jointm.2024.06.002","DOIUrl":"10.1016/j.jointm.2024.06.002","url":null,"abstract":"<div><h3>Background</h3><div>The purpose is to formulate a modified screening protocol for acute respiratory distress syndrome (ARDS) in patients with respiratory support based on saturation of pulse oximetry (SpO<sub>2</sub>) and inspired oxygen concentration (FiO<sub>2</sub>).</div></div><div><h3>Methods</h3><div>This prospective observational study was conducted from August to October 2020 at the Department of Critical Care Medicine of Yijishan Hospital Affiliated with Wannan Medical College. All patients admitted during the study period and required arterial blood gas analysis and electrocardiogram monitoring were included in this study. Patients with contraindications to arterial puncture, methemoglobinemia, carbon monoxide poisoning, and other factors that could affect data collection were excluded. The demographic and clinical data, immediate percutaneous SpO<sub>2</sub>, FiO<sub>2</sub>, arterial oxygen partial pressure (PaO<sub>2</sub>), and respiratory rate were recorded; and the SpO<sub>2</sub>/FiO<sub>2</sub> ratio (SFR) and PaO<sub>2</sub>/FiO<sub>2</sub> ratio (PFR) values were calculated according to the above information. The patients were divided into two cohorts by random number table: the establishment cohort and the verification cohort. In the established part, data were divided into group H and group N according to whether SpO<sub>2</sub> &gt;97 %. For group H (SpO<sub>2</sub> ≤97 %), the regression equation was established between SFR and PFR. For group N (SpO<sub>2</sub> &gt;97 %), the correlation between each observation data and PFR was analyzed. Then, a new diagnostic process was established, and the reliability was verified with the Berlin definition set as the gold standard for diagnosis and classification.</div></div><div><h3>Results</h3><div>There were 341 patients were included. Among them, 161 patients were used to establish the model, and 180 patients were used to verify the validity of the model. In this new diagnosis progress, when SpO<sub>2</sub> ≤97 %, if SFR ≤352, ARDS may exist; when SpO<sub>2</sub> &gt;97 %, if FiO<sub>2min</sub> &gt;39 %, there may be ARDS. The sensitivity, specificity, negative predictive value, positive predictive value, and accuracy of the new diagnosis progress for ARDS were 91.1 %, 76.7 %, 89.6 %, 79.6 %, and 83.9 %, respectively.</div></div><div><h3>Conclusion</h3><div>The SpO<sub>2</sub>/FiO<sub>2</sub> ratio demonstrates notable sensitivity and specificity in diagnosing ARDS, presenting as a credible alternative to PFR.</div><div><strong>Trail Registration</strong> Chinese Clinical Trial Registry Identifier: ChiCTR2000029217</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 1","pages":"Pages 51-57"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11763540/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143054384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The pros and cons of beta-blockers in sepsis: Where do we stand in 2024? β受体阻滞剂治疗败血症的利弊:2024年我们将站在哪里?
Pub Date : 2025-01-01 DOI: 10.1016/j.jointm.2024.07.002
Daniel De Backer , Dechang Chen
{"title":"The pros and cons of beta-blockers in sepsis: Where do we stand in 2024?","authors":"Daniel De Backer ,&nbsp;Dechang Chen","doi":"10.1016/j.jointm.2024.07.002","DOIUrl":"10.1016/j.jointm.2024.07.002","url":null,"abstract":"","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 1","pages":"Pages 32-34"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11763536/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143054420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolomic profiling and prognostication in COVID-19 acute respiratory distress syndrome COVID-19 急性呼吸窘迫综合征的代谢组学分析和预后分析
Pub Date : 2025-01-01 DOI: 10.1016/j.jointm.2024.04.001
David Furfaro , Xiaoyu Che , Wenhao Gou , Matthew J. Cummings , Nischay Mishra , Daniel Brodie , Thomas Briese , Oliver Fiehn , W. Ian Lipkin , Max R. O'Donnell
{"title":"Metabolomic profiling and prognostication in COVID-19 acute respiratory distress syndrome","authors":"David Furfaro ,&nbsp;Xiaoyu Che ,&nbsp;Wenhao Gou ,&nbsp;Matthew J. Cummings ,&nbsp;Nischay Mishra ,&nbsp;Daniel Brodie ,&nbsp;Thomas Briese ,&nbsp;Oliver Fiehn ,&nbsp;W. Ian Lipkin ,&nbsp;Max R. O'Donnell","doi":"10.1016/j.jointm.2024.04.001","DOIUrl":"10.1016/j.jointm.2024.04.001","url":null,"abstract":"","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 1","pages":"Pages 108-110"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141037971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of intensive medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1